Recently, numerous studies have found that increased expression of IL-23 is involved in the pathogenesis of many autoimmune diseases, such as inflammatory bowel disease, Crohn’s disease (CD)[15], and multiple sclerosis (MS)[22]. Here, IL23A is linked to multiple sclerosis.